COMP <GO>
CSL vs CLX // FORWARD P/E MULTIPLE
Carlisle Companies Incorporated (NYSE) VS. Clorox Company (NYSE) • 15-METRIC TALLY: CSL 7
— CLX 7
▲ FORWARD P/E MULTIPLE LEADER: CLX
LAST: $376.31 (+1.33%) • MKT CAP: $14.54B
forward-pe
18.5x
LAST: $88.00 (-0.76%) • MKT CAP: $10.64B
forward-pe
12.1x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CSL VS. CLX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CSL | CLX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 35.70% | 45.20% | -9.50 | CLX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 22.20% | 37.20% | -15.00 | CLX | /roic <GO> |
| EV/EBITDA & P/E Valuation | 14.8x | 10.9x | +3.90 | CLX | /valuation <GO> |
| Free Cash Flow Yield | 6.58% | 7.10% | -0.52 | CLX | /fcf-yield <GO> |
| Operating Margin | 20.00% | 14.20% | +5.80 | CSL | /operating-margins <GO> |
| Net Profit Margin | 14.80% | 11.60% | +3.20 | CSL | /net-margins <GO> |
| Revenue Growth (YoY) | 0.30% | 0.20% | +0.10 | CSL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.23% | 5.61% | -4.38 | CLX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.21 | 2.93 | +3.28 | CSL | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | CLX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 69.4 | 53.3 | +16.10 | CSL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.08 | 0.93 | +0.15 | CSL | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 18.5x | 12.1x | +6.40 | CLX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $14.54B | $10.64B | $3.90B | CSL | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CSL REV | CLX REV | CSL GROSS % | CLX GROSS % | CSL FCF | CLX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.02B | $7.10B | 35.7% | 45.2% | $970.6M | $761.0M |
| FY 2024 | $5.00B | $7.09B | 37.7% | 43.0% | $917.0M | $483.0M |
| FY 2023 | $4.59B | $7.39B | — | — | $994.9M | $825.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CSL // BETA 1.08
CLX // BETA 0.93